You are using an outdated browser. Please upgrade your browser to improve your experience.
ClinTrial Refer LYSA

LYSARC (Lymphoma Studies Academic Research Company) was founded in 2012 following the merger of two leading academic groups (GELA and GOELAMS) who decided to combine their clinical experience, methodological expertise and access to patients

LYSARC (Lymphoma Studies Academic Research Company) was founded in 2012 following the merger of two leading academic groups (GELA and GOELAMS) who decided to combine their clinical experience, methodological expertise and access to patients

ClinTrial Refer LYSA

by Roslyn Ristuccia
ClinTrial Refer LYSA
ClinTrial Refer LYSA
ClinTrial Refer LYSA

What is it about?

LYSARC (Lymphoma Studies Academic Research Company) was founded in 2012 following the merger of two leading academic groups (GELA and GOELAMS) who decided to combine their clinical experience, methodological expertise and access to patients. This merger created a world-class specialist research organization in the field of lymphoma. LYSARC objective is to improve the access of innovative therapies for lymphoma patients. LYSARC is a nonprofit trust governed by an independent Board composed of leading clinicians and pathologists with international reputation in the field of lymphoma research. For each trial, you will find the acronym, title of trial, population, trials details, inclusion and exclusion criteria.

ClinTrial Refer LYSA

App Details

Version
1.1
Rating
NA
Size
9Mb
Genre
Medical Reference
Last updated
October 25, 2016
Release date
September 16, 2016
More info

App Screenshots

ClinTrial Refer LYSA screenshot-0
ClinTrial Refer LYSA screenshot-1
ClinTrial Refer LYSA screenshot-2
ClinTrial Refer LYSA screenshot-3
ClinTrial Refer LYSA screenshot-4

App Store Description

LYSARC (Lymphoma Studies Academic Research Company) was founded in 2012 following the merger of two leading academic groups (GELA and GOELAMS) who decided to combine their clinical experience, methodological expertise and access to patients. This merger created a world-class specialist research organization in the field of lymphoma. LYSARC objective is to improve the access of innovative therapies for lymphoma patients. LYSARC is a nonprofit trust governed by an independent Board composed of leading clinicians and pathologists with international reputation in the field of lymphoma research. For each trial, you will find the acronym, title of trial, population, trials details, inclusion and exclusion criteria.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.